sevelameerhydrochloride waymade 400 mg, filmomhulde tabletten
waymade b.v. strawinskylaan 3127 1077 zx amsterdam - sevelameerhydrochloride - filmomhulde tablet - crospovidon (e 1202) ; hyprolose (e 463) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; magnesiumstearaat (e 470b) ; polyethyleenglycol (e 1521) ; siliciumdioxide (e 551) ; sorbitol (d-)(e 420) ; titaandioxide (e 171) - sevelamer
sevelameerhydrochloride waymade 800 mg, filmomhulde tabletten
waymade b.v. strawinskylaan 3127 1077 zx amsterdam - sevelameerhydrochloride 800 mg/stuk - filmomhulde tablet - crospovidon (e 1202) ; hyprolose (e 463) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; magnesiumstearaat (e 470b) ; polyethyleenglycol (e 1521) ; siliciumdioxide (e 551) ; sorbitol (d-)(e 420) ; titaandioxide (e 171) - sevelamer
sitagliptine/metformine hydrochloride grindeks 50 mg/1000 mg, filmomhulde tabletten
metforminehydrochloride 1000 mg/stuk samenstelling overeenkomend met ; metformine 779,6 mg/stuk ; sitagliptinehydrochloride 1-water 56,7 mg/stuk samenstelling overeenkomend met ; sitagliptine 50 mg/stuk - filmomhulde tablet - cellulose, microkristallijn (e 460(i)) ; copolymeer van macrogol (25,0)-poly(vinyl alcohol) (75,0) (e 1209) ; glycerol monocaprylocapraat, type i ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; ijzeroxide zwart (e 172) ; natriumlaurilsulfaat ; natriumstearylfumaraat ; polyvinylalcohol, gedeeltelijk gehydrolyseerd (e1203) ; povidon k 30 (e 1201) ; talk (e 553 b) ; titaandioxide (e 171), cellulose, microkristallijn (e 460) ; copolymeer van macrogol (25,0)-poly(vinyl alcohol) (75,0) ; glycerol monocaprylocapraat, type i ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; ijzeroxide zwart (e 172) ; natriumlaurilsulfaat (e 487) ; natriumstearylfumaraat ; polyvinylalcohol, gedeeltelijk gehydrolyseerd (e1203) ; povidon k 30 (e 1201) ; talk (e 553 b) ; titaandioxide (e 171)
sitagliptine/metformine hydrochloride grindeks 50 mg/850 mg, filmomhulde tabletten
metforminehydrochloride 850 mg/stuk samenstelling overeenkomend met ; metformine 662,7 mg/stuk ; sitagliptinehydrochloride 1-water 56,7 mg/stuk samenstelling overeenkomend met ; sitagliptine 50 mg/stuk - filmomhulde tablet - cellulose, microkristallijn (e 460(i)) ; copolymeer van macrogol (25,0)-poly(vinyl alcohol) (75,0) (e 1209) ; glycerol monocaprylocapraat, type i ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; natriumlaurilsulfaat ; natriumstearylfumaraat ; polyvinylalcohol, gedeeltelijk gehydrolyseerd (e1203) ; povidon k 30 (e 1201) ; talk (e 553 b) ; titaandioxide (e 171), cellulose, microkristallijn (e 460) ; copolymeer van macrogol (25,0)-poly(vinyl alcohol) (75,0) ; glycerol monocaprylocapraat, type i ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; natriumlaurilsulfaat (e 487) ; natriumstearylfumaraat ; polyvinylalcohol, gedeeltelijk gehydrolyseerd (e1203) ; povidon k 30 (e 1201) ; talk (e 553 b) ; titaandioxide (e 171)
metformine hydrochloride mylan 1000 mg, filmomhulde tabletten
mylan b.v. dieselweg 25 3752 lb bunschoten - metforminehydrochloride - filmomhulde tablet - hypromellose (e 464) ; magnesiumstearaat (e 470b) ; polyethyleenglycol (e 1521) ; povidon (e 1201), - metformin
metformine hydrochloride mylan 500 mg, filmomhulde tabletten
mylan b.v. dieselweg 25 3752 lb bunschoten - metforminehydrochloride - filmomhulde tablet - hypromellose (e 464) ; magnesiumstearaat (e 470b) ; polyethyleenglycol (e 1521) ; povidon (e 1201), - metformin
metformine hydrochloride mylan 850 mg, filmomhulde tabletten
mylan b.v. dieselweg 25 3752 lb bunschoten - metforminehydrochloride - filmomhulde tablet - hypromellose (e 464) ; magnesiumstearaat (e 470b) ; polyethyleenglycol (e 1521) ; povidon (e 1201), - metformin
vildagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, type 2 - geneesmiddelen die worden gebruikt bij diabetes - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 en 5. 1 voor de beschikbare gegevens over verschillende combinaties).
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, metformine hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 en 5. 1 voor de beschikbare gegevens over verschillende combinaties).
targinact 30 mg - 15 mg tabl. verl. afgifte
mundipharma bv-srl - oxycodonhydrochloride 30 mg - eq. oxycodon 27 mg; naloxonhydrochloride 15 mg - eq. naloxon 13,5 mg - tablet met verlengde afgifte - 30 mg - 15 mg - oxycodonhydrochloride 30 mg; naloxonhydrochloride 15 mg - oxycodone, combinations